GNPX קפיטליזציה חשבונאית genprex.com

Genprex, Inc. (GNPX) is implementing advanced methods for transporting functional genes to affected areas in cases of diabetes and lung cancer. Current price action on GURU.Markets, recorded at 0.02, complements data regarding the use of AI and robotics to automate nanoparticle treatment. Meanwhile, management is strictly adhering to the clinical trial schedule, maintaining investor confidence in the success of its developments.

Full capacity utilization of Genprex, Inc. (GNPX) laboratories for the creation of viral vectors requires significant capital expenditures, which is directly reflected in the net asset value. By analyzing the company's capital history on the balance sheet, an investor assesses the difference between all assets and liabilities, determining the real intrinsic value of the business and the degree of capital protection against debt risks during market volatility.